Please login to the form below

Not currently logged in
Email:
Password:

Trelegy

This page shows the latest Trelegy news and features for those working in and with pharma, biotech and healthcare.

GSK boosts outlook thanks to strong respiratory and vaccine sales

GSK boosts outlook thanks to strong respiratory and vaccine sales

New launches for respiratory products Nucala (mepolizumab) and Trelegy (vilanterol/umeclidinium/ fluticasone furoate) helped boost revenues in this area, bringing in £203m and £139m respectively. ... This was due to Nucala receiving EU approval for self

Latest news

More from news
Approximately 5 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...

Infographics